Business · 10/05/2019
FDA Announces Final Guidance to Reduce Risk of Babesiosis in Blood Transfusions
The Food and Drug Administration has released a final guidance document outlining recommendations to minimize the risk of babesiosis transmission through blood transfusions, a serious transfusion-transmitted infection (RTTI) identified by the FDA.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →